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Summary: From 2000 sera with elevated total creatine kinase (EC 2.7.3.2) activity the sera of 6 patients showed a
persistent high and anamnestically inexplicable creatine kinase activity level. The serum isoenzyme pattern was
analyzed by four different methods. Electrophoresis revealed an atypical creatine kinase activity band located
between creatine kinase-MM and creatine kinase-MB. An adequate estimation of the persistent enzyme activity
could only be achieved by immunotitration (immunoprecipitation), which identified the creatine kinase activity as
due primarily to the isoenzyme creatine kinase-BB. Other methods (immunoinhibition and column chromato-
graphy) may lead to misinterpretations. The atypical serum creatine kinase-BB showed a higher molecular weight
(MT = 250,000) and altered substrate affinity as compared to native creatine kinase-BB. Both properties are
attributable to the binding of creatine kinase-BB to immunoglobulins.
Makro-Kreatinkinase-BB: Beobachtungen an 6 Patienten
Zusammenfassung: Unter etwa 2000 untersuchten Seren mit erhöhter Aktivität der Kreatinkinase (EC 2.7.3.2)
fielen die Seren von 6 Patienten mit einer konstanten und anamnestisch nicht erklärbaren Kreatinkinase-Aktivität
auf. Das Isoenzymverteilungsmuster wurde mit 4 verschiedenen analytischen Methoden differenziert. Die Elektro-
phorese zeigte jeweils eine einzige Kreatinkinase-Bande, die zwischen Kreatinkinase-MM und Kreatinkinase-MB i
lokalisiert war. Eine spezifische Zuordnung gelang nur mit Hilfe der Immuntitration (Immunpräzipitation), die :
die Kreatinkinase-Aktivität als vorwiegend aus dem Isoenzym Kreatinkinase-BB bestehend identifizierte. Die Er- :
gebnisse der Immuninhibition und der Säulenchromatographie können zu Mißdeutungen führen. Die atypische Serum-
Kreätiiikinase-BB-Aktivität im Serum war sowohl mit einem Molekulargewicht von MT 250,000 als auch hinsichtlich ;
ihrer Substrataffinität von nativer Gewebs-BB verschieden. Beide Eigenschaften sind auf eine Bindung zwischen !
Kreatinkinase-BB und Immunglobulinen zurückzuführen.
Introduction activity to be creatine kinase-BB (2). The cause of the
, cathodic location is assumed to be an elevated molecularIn the last three years repeated reports have appeared on rf ^^ ̂ ^ ßß as g ̂  rf aeodatton
atypical isoenzyme distribution of creatine kinase immunoglobulins G and A (5,8). At present there is |
(EC. 2.7.3.2) (1-8). Electrophoretic investigations (3,4, no izab,e connection with uniform etiological
5,7) show an- enzyme activity located between creatine Qr ^ factors
kinase-MM and creatine kinase-MB. However, imniuno-
logical determination methods prove this isoenzyme From approximately 2000 patients with elevated
· creatine kinase activity we found an atypical isoenzyme
*) Supported by the Deutsche Forschungsgemeinschaft distribution pattern in the sera of 6 patients. The
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patients manifested a regularly detectable and anam-
nestically inexplicable increase in total creatine kinase
activity. The creatine kinase-MB activity in the serum
was usually higher than total activity after application
of the immunoinhibition test (MERCK- 1-TEST-CK-MB),
This observation led us to characterize the isoenzyme
distribution in greater detail by further analytical
methods, to define the substrate affinity in comparison
with the other isoenzymes by kinetic investigations, and
to determine the molecular weight by gel filtration.
Materials and Methods
The total creatine kinase activity was measured with a GSH-
activated and - after the introduction of the N-acety Icy steine
(NAC) recommended as an activator by the German Society
for Clinical Chemistry (9) - with an N-acety Icy ste.ine-activated
creatine kinase-test kit. The creatine kinase-MB activity was
determined with MERCK-1-TEST-CK-MB (Cat. No. 14300,
initially GSH-activated, later NAC-activated) by immuno-
inhibition (10) of the creatine kinase-M subunits. The isoen-
zymes were specifically differentiated by immunotitration
(immunoprecipitation (11,12)) with anti-creatine kinase-MM
and anti-creatine kinase-BB (both anti-sera from MERCK,
Cat.No. 11642 and 11643), the residual activities being meas?
ured after precipitation (1 hour at +37 °C and 15 hours at
+4 °C) and centrifugation (Eppendorf centrifuge, 5 min at
9,000#) with an N-acetylcysteine-activated creatine kinase-
kit. Reference studies were performed by a modification of
Mercer's column chromatography technique (13) (TC-
BOEHR1NGER, Cat.No. 189219). Measurements were per-
formed with an Eppendorf photometer, 334 nm, +25 °C.
The electrophoresis was carried out on cellulose acetate
strips (SCHLEICHER & SCHÜLL) with a constant voltage
of 200 V, over a period of 1 hour. The bands containing
creatine kinase activity were developed under UV light after
30 minutes of incubation of the strips on a agarose-substrate
(NAC-BOEHRINGER) mixture. Strips that had been incubated
without creatine phosphate served as controls. As a refer-
ence serum we used that of a patient with severe intoxication
(total creatine kinase activity 7000 U/l, creatine kinase-MB
fraction 0.04) enriched with the same amount of human
creatine kinase-BB.
The molecular weight was determined with calibration
proteins (BOEHRINGER) by gel filtration (Sepharose-6B,
column 600 X 25 mm, phosphate 50 mmol/1, pH 7,2
emission volume 85 ml). For the molecular weight determ-
ination we used 1 ml (400 U) of the serum of patient 1
(2nd fraction from the column chromatography).
Patients
Age, sex, and clinical diagnoses of the patients are listed in
table 1,
Patients
The results of the enzyme activity determinations ob-
tained by the various methods are listed in table 2. Ana-
lysis of the eluates of column chromatography by
immunotitration yielded for the first fraction (=
"creatine kinase-MM") a mixture of creatine kinase-MM
and creatine kinase.BB and for the second fraction
(= "creatine kinase-MB") only creatine kinase-BB (tab. 3).
The electrophoretic studies on selected serum samples
(patients 1, 2, 4, 5 and 6) showed in each case a single
creatine kinase band which in contrast to the known
isoenzyme distribution of the reference serum,· was
located between creatine kinase-MM and creatine kinase-
MB (fig. 1).
The second fraction from the column chromatography
yielded creatine kinase-BB with a sufficient activity. We
compared the substrate affinities of creatine kinase-BB
prepared and purified from human tissue (14) with that
isolated by column chromatography from human serum.
Fig. 1. Electrophoresis showed in each case a single creatine
kinase band which, in contrast to the known isoenzyme
distribution of the reference serum, was located between
creatine kinase-MM and creatine kinase-MB. From left
to right: reference serum, patient 1,2,4,5 and 6.























Coronary heart disease, subclinical diabetes mellitus, hyperlipoproteinemia type
IV, inferior myocardial infarction May 5th 19771
Coronary heart disease, subclinical diabetes mellitus.
Combined mitral valve defect, stage III-IV, embolism into the ramus interven-
tricularis anterior during cardiac catheterism May 25 th 1977.
Bronchial asthma
Coronary heart disease, diabetes mellitus, pneumonia.
Coronary heart disease, hypertension, hypercholesterolemia, anterior-wall myo-
eardial reinfarction June 18th, 1978.
"Kindly supplied by Prof. Dr. Venrath and Dr. Waldecker, Hospital Porz/Rhein.
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Tab. 3. Analysis of column chromatography eluates by immuno-
precipitation gave for the first fraction (= "creatine-
kinase-MM") a mixture of creatine kinase-MM and
creatine kinase-BB and for the second fraction (=





































The differences in substrate affinities of both enzymes
for creatine phosphate and adenosine diphosphate are
presented in table 4.
A molecular weight of 250,000 Daltons was determined
for the atypical creatine kinase-BB by gel filtration (fig. 2).
This value was reproducible both for the native serum and
Tab. 4. The differences of the substrate affinity (Michaelis
constants) of creatine kinase-BB from human tissue and
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+ after Szasz (14)
for the second fraction from the column chromatography.
A molecular weight of 85,000 Daltons was determined for
creatine kinase-BB obtained from myometrial smooth
muscle.
We were able to examine the serum samples from patient
1 over a period of 20 months. Creatine kinase-BB was
detected regularly throughout this time, though the level
of the activity varied. No creatine kinase-B activity was
found with the immunoinhibition test in this patient's
three children.
In patient 6 we were able to examine the serum samples
shortly after an acute myocardial infarction (7 hours
after the onset of pain) and to study them over 3 days at
short intervals. The immunptitration confirmed creatine
kinase-MB activity only during the acute-phase of in-
farction; no creatine kiriase-MB was detected in the con-
valescence period. Creatine kinase-BB was, however,
found to be constant in all samples and in all phases.
Discussion
The atypical creatine kinase activity was studied by 4
different analytical methods (immunoinhibition,
immunotitration, column chromatography, and elec-
trophoresis) for its relationship to the known iso-
enzyme distribution pattern. The results obtained by
each of the 4 methods are contradictory and could
give rise to misinterpretations.
The immunoinhibition seems to show in all 6 patients
an exceptionally high creatine kinase-MB content.
However, after inhibition of the creatine kinase-M
subunits, this method measures only the remaining
creatine kinase^B subunit activity, regardless of whether
this is to be attributed to creatine kinase--MB or creatine
kinase-BB. In all the samples studied by immunotitration,
however, the creatine kinase activity could be identified






Cdibration proteins (A/ r)
- Ferritin (540000)




-* Alkaline phosphdtase (100000)
- Bovine albumin (67000)
*· <x-Amylase(45000)
' Gytochrome c (11000)
Fig. 2. A molecular weight of Μτ 250,000 was determined for the atypical creatine kinase-BB (Sepharose 6B) ® — ®) and
of MT 85,000 for tissue creatine kinase-BB (myometrial smooth muscle, Sephadex G 200 Ξ — 0) by gel filtration.
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The use of Mercer's modification (13) of column chro-
matography also simulates a high creatine kinase-MB
content. Specific testing of the eluates with immunotitra-
tion gave for the first fraction ("creatine kinase-MM") a
mixture of creatine-kinase-MM and creatine kinase-BB,
and for the second fraction ("creatine kinase-MB") only
creatine kinase-BB. The atypical electrophoretic loca-
tion — all the enzyme activity was located in one band
between creatine kinase-MM and creatine kinase-MB - in-
dicates a changed mobility of the variant creatine kinase
activity. This altered mobility is also the reason that the
column chromatography simulates "creatine kinase-MB"
activity in the eluate with the high salt content.
The atypical migration of the enzyme activity is obvi-
ously due to its high molecular weight (MT = 250,000)
compared to the molecular weight of native creatine
kinase isoenzymes (MT = 80,000, (15, 16)). Urdal &
Landaas (5) have detected a binding of serum creatine
kinase-BB to immunoglobulin G. As shown by Jockers-
Wretou &Plessing (8), this is also the case for 5 of the
six reported patients. The alteredM/c/zae//s constants of
the creatine kinase-BB enzyme thus could be explained
by steric hindrance.
The total creatine kinase activities are as a rule elevated,
but normal activities (see patient 6) do not exclude
presence of creatine kinase-BB. Since on the whole
elevated total creatine kinase activities motivate iso-
enzyme differentiation, the frequency of patients with
this phenomenon may be greater than indicated by the
patient material examined so far (Lang et al. (2) 1:
lQQO,Ljungdahlet al. (4) 1: 800, Urdal et al. (5)
5:310, our observation 6 : 2000 patients). Until now
the study of relatives (patient 1, see also I.e. (2)) has
given no evidence for a familial-genetic disposition. With
few exceptions (patient 4, see also I.e. (2,4)), the patients
involved are elderly (average age 66.4 years). The sex
distribution shows a bias toward women, if the data from
comparable studies (2,4,5,6) are included (female:male
= 31:8).
Addendum
In the meantime two additional reports due to the problem of
macro-creatine kinase-BB are published:
Stein, W. & Bonner, J. (1979), Clin. Chem. 25, 1513-1514.
Bohner, J., Stein W., Kuhlmann, E. & Eggstein, M. (1979),
Clin. Chim. Acta P7, 83-88.
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